AllianceBernstein’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.42M | Buy |
40,888
+783
| +2% | +$29.3K | ﹤0.01% | 2182 |
|
|
2025
Q4 | $1.4M | Buy |
40,105
+844
| +2% | +$66.3K | ﹤0.01% | 2191 |
|
|
2025
Q3 | $3.26M | Sell |
39,261
-29,803
| -43% | -$2.16M | ﹤0.01% | 1731 |
|
|
2025
Q2 | $5.07M | Sell |
69,064
-68,030
| -50% | -$4.93M | ﹤0.01% | 1475 |
|
|
2025
Q1 | $15.7M | Sell |
137,094
-33,775
| -20% | -$2.06M | 0.01% | 964 |
|
|
2024
Q4 | $8.61M | Sell |
170,869
-15,270
| -8% | -$800K | ﹤0.01% | 1251 |
|
|
2024
Q3 | $8.61M | Sell |
186,139
-13,215
| -7% | -$470K | ﹤0.01% | 1267 |
|
|
2024
Q2 | $6.48M | Hold |
199,354
| – | – | ﹤0.01% | 1385 |
|
|
2024
Q1 | $5.02M | Sell |
199,354
-45,141
| -18% | -$1.07M | ﹤0.01% | 1466 |
|
|
2023
Q4 | $7.94M | Buy |
244,495
+66,370
| +37% | +$1.82M | ﹤0.01% | 1277 |
|
|
2023
Q3 | $4.85M | Sell |
178,125
-9,099
| -5% | -$263K | ﹤0.01% | 1441 |
|
|
2023
Q2 | $4.17M | Sell |
187,224
-4,200
| -2% | -$96.7K | ﹤0.01% | 1505 |
|
|
2023
Q1 | $4.15M | Sell |
191,424
-14,140
| -7% | -$310K | ﹤0.01% | 1470 |
|
|
2022
Q4 | $4.18M | Buy |
205,564
+156
| +0.1% | +$3.91K | ﹤0.01% | 1515 |
|
|
2022
Q3 | $5.27M | Buy |
205,408
+79
| +0% | +$2.11K | ﹤0.01% | 1377 |
|
|
2022
Q2 | $4.88M | Sell |
205,329
-4,626
| -2% | -$101K | ﹤0.01% | 1465 |
|
|
2022
Q1 | $4.73M | Sell |
209,955
-24,986
| -11% | -$532K | ﹤0.01% | 1611 |
|
|
2021
Q4 | $4.65M | Sell |
234,941
-109,863
| -32% | -$2.23M | ﹤0.01% | 1660 |
|
|
2021
Q3 | $6.79M | Buy |
344,804
+103,610
| +43% | +$2.17M | ﹤0.01% | 1447 |
|
|
2021
Q2 | $5.31M | Sell |
241,194
-6,340
| -3% | -$141K | ﹤0.01% | 1579 |
|
|
2021
Q1 | $5.89M | Buy |
247,534
+1,400
| +0.6% | +$37.4K | ﹤0.01% | 1464 |
|
|
2020
Q4 | $6.44M | Hold |
246,134
| – | – | ﹤0.01% | 1352 |
|
|
2020
Q3 | $4.28M | Sell |
246,134
-26,906
| -10% | -$429K | ﹤0.01% | 1413 |
|
|
2020
Q2 | $4.59M | Buy |
273,040
+1,020
| +0.4% | +$14.3K | ﹤0.01% | 1366 |
|
|
2020
Q1 | $3.23M | Buy |
272,020
+1,950
| +0.7% | +$24.1K | ﹤0.01% | 1403 |
|
|
2019
Q4 | $3.27M | Sell |
270,070
-7,550
| -3% | -$105K | ﹤0.01% | 1675 |
|
|
2019
Q3 | $3.92M | Sell |
277,620
-24,150
| -8% | -$297K | ﹤0.01% | 1548 |
|
|
2019
Q2 | $3.37M | Buy |
301,770
+42,500
| +16% | +$474K | ﹤0.01% | 1660 |
|
|
2019
Q1 | $3.04M | Hold |
259,270
| – | – | ﹤0.01% | 1667 |
|
|
2018
Q4 | $3.46M | Hold |
259,270
| – | – | ﹤0.01% | 1506 |
|
|
2018
Q3 | $3.63M | Hold |
259,270
| – | – | ﹤0.01% | 1511 |
|
|
2018
Q2 | $4.08M | Buy |
259,270
+36,760
| +17% | +$640K | ﹤0.01% | 1390 |
|
|
2018
Q1 | $3.66M | Sell |
222,510
-25,180
| -10% | -$467K | ﹤0.01% | 1394 |
|
|
2017
Q4 | $4.47M | Sell |
247,690
-12,670
| -5% | -$229K | ﹤0.01% | 1287 |
|
|
2017
Q3 | $5.03M | Sell |
260,360
-38,180
| -13% | -$569K | ﹤0.01% | 1205 |
|
|
2017
Q2 | $3.52M | Sell |
298,540
-50,140
| -14% | -$545K | ﹤0.01% | 1431 |
|
|
2017
Q1 | $3.82M | Sell |
348,680
-54,260
| -13% | -$477K | ﹤0.01% | 1355 |
|
|
2016
Q4 | $2.92M | Buy |
402,940
+2,700
| +0.7% | +$21.2K | ﹤0.01% | 1564 |
|
|
2016
Q3 | $2.6M | Buy |
400,240
+176,920
| +79% | +$1.03M | ﹤0.01% | 1577 |
|
|
2016
Q2 | $1.22M | Buy |
223,320
+149,120
| +201% | +$776K | ﹤0.01% | 2106 |
|
|
2016
Q1 | $347K | Hold |
74,200
| – | – | ﹤0.01% | 2533 |
|
|
2015
Q4 | $370K | Sell |
74,200
-2,500
| -3% | -$11.3K | ﹤0.01% | 2555 |
|
|
2015
Q3 | $288K | Sell |
76,700
-1,500
| -2% | -$7.61K | ﹤0.01% | 2675 |
|
|
2015
Q2 | $470K | Buy |
78,200
+8,400
| +12% | +$51.5K | ﹤0.01% | 2607 |
|
|
2015
Q1 | $391K | Buy |
69,800
+700
| +1% | +$2.53K | ﹤0.01% | 2579 |
|
|
2014
Q4 | $207K | Hold |
69,100
| – | – | ﹤0.01% | 2795 |
|
|
2014
Q3 | $185K | Hold |
69,100
| – | – | ﹤0.01% | 2800 |
|
|
2014
Q2 | $193K | Sell |
69,100
-8,600
| -11% | -$25.4K | ﹤0.01% | 2823 |
|
|
2014
Q1 | $339K | Sell |
77,700
-3,800
| -5% | -$13.3K | ﹤0.01% | 2571 |
|
|
2013
Q4 | $262K | Sell |
81,500
-23,400
| -22% | -$47.3K | ﹤0.01% | 2711 |
|
|
2013
Q3 | $167K | Sell |
104,900
-3,207
| -3% | -$5.66K | ﹤0.01% | 2895 |
|
|
2013
Q2 | $187K | Buy |
+108,107
| New | +$194K | ﹤0.01% | 2859 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
AllianceBernstein's CORT Position: Q1 2026 in Review
AllianceBernstein increased its Corcept Therapeutics (CORT) stake by 2% in Q1 2026, buying an estimated $29.3K and bringing the position to 40,888 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2182.
AllianceBernstein first reported a position in CORT in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.7M in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- AllianceBernstein held 40,888 shares of Corcept Therapeutics worth $1.42M as of Q1 2026.
- AllianceBernstein bought 783 Corcept Therapeutics shares in Q1 2026, an estimated $29.3K.
- Corcept Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2182 holding.
- AllianceBernstein first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Corcept Therapeutics position peaked at $15.7M in Q1 2025.
- 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.